This week, the ratings of 10 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
JAZZ
Recent Articles
Is 70% an Excessive Premium for Celator Pharmaceuticals Inc? (CPXX JAZZ)
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense? More
9 Biotech Stocks That Will Go Boom or Bust
A bunch of biotech stocks are knocking on the door of news that could prove to be very good or very bad. More
The Best 7 Stocks to Buy for 2016
Was 2015 the final nail in the coffin for buy-and-hold investing? Not necessarily. Buy these 7 names and hold for 2016 before letting them go More
Buy These 5 On-Sale Biopharma Stocks NOW (AMAG, AKRX, JAZZ, MNK, PCRX)
While the rest of the market is enjoying a healthy start to the fall, biopharma stocks continue to lag. Here are 5 pharma stocks on sale now More
4 (More) Biotech Stocks to Buy
Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration. More
2 Biotech Stocks to Buy After Earnings
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy. More
